We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,198.60
Bid: 1,198.40
Ask: 1,198.60
Change: 7.80 (0.66%)
Spread: 0.20 (0.02%)
Open: 1,202.60
High: 1,215.20
Low: 1,195.80
Yest. Close: 1,190.80
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Suntory to buy GSK drinks brands for $2.1 bln

LONDON, Sept 9 (Reuters) - Japan's Suntory Beverage & Food Ltd has agreed to buy the Lucozade and Ribena brands from GlaxoSmithKline Plc for 1.35 billion pounds ($2.11 billion) in a deal that boosts its soft drinks portfolio and helps it expand into new markets. The acquisition, announced b

9 Sep 13 07:35

GlaxoSmithKline Sells Ribena, Lucozade To Japan's Suntory - The Telegraph

9 Sep 13 05:57

Study reassures on safety of inhaled lung treatment

* No increased risk seen with Boehringer's Spiriva Respimat * New study contrasts with safety concerns raised in 2011 LONDON, Sept 8 (Reuters) - A major study on the safety of a mist inhaler used to treat chronic lung disease has found it does not increase the risk of patients dying e

8 Sep 13 10:50

UPDATE 2-Glaxo pulmonary drug seen closer to approval by FDA -analysts

* FDA review of Glaxo/Theravance drug backs efficacy * FDA notes some inconsistencies in safety data * Analysts believe review broadly positive (Adds analyst comments, stock prices) By Toni Clarke WASHINGTON, Sept 6 (Reuters) - A U.S. Food and Drug Administration review

6 Sep 13 15:20

UPDATE 1-Safety data inconclusive on Glaxo pulmonary drug -FDA staff

(Adds FDA reviewer comments on cardiovascular safety) WASHINGTON, Sept 6 (Reuters) - An experimental drug to treat chronic obstructive pulmonary disease made by GlaxoSmithKline Plc and Theravance Inc appears to work, but the safety data is not entirely conclusive, reviewers for the U.S. Foo

6 Sep 13 13:43

Safety data on Glaxo COPD drug inconclusive -FDA staff

Sept 6 (Reuters) - An experimental drug to treat chronic obstructive pulmonary disease made by GlaxoSmithKline Plc and Theravance Inc appears to work, but its safety data are not entirely conclusive, according to medical reviewers for the U.S. Food and Drug Administration. The reviewers po

6 Sep 13 12:59

UK Winners & Losers: Pharmas Struggle; Tullow Oil Leads After Discovery

6 Sep 13 11:51

Update-Moody's looks at Suntory's possible acquisition of GSK's beverage brands

Suntory Holdings Limited (Suntory) & GlaxoSmithKline plc (GSK)

6 Sep 13 10:38

Friday newspaper round-up: North Sea, Glaxo, Wonga

Government borrowing costs in the US and Europe surged as investors became more optimistic that the developed world has embarked on a period of sustained and rapid growth and anticipated that central banks will increase interest rates earlier than previously thought. Yields on sovereign debt, which

6 Sep 13 07:30

UPDATE 2-Suntory closing in on deal to buy GSK drinks brands -sources

* Sale to Japan's Suntory would pre-empt auction -sources * Deal for Lucozade, Ribena could be announced in days * Price expected to be more than 1 billion pounds * Suntory flush with cash for M&As after $4 bln IPO By Anjuli Davies and Ben Hirschler LONDON, Sept 5 (R

6 Sep 13 06:17

London close: FTSE 100 at three-week high after policy meetings

A host of central-bank policy meetings, a dovish tone from Mario Draghi and the continued improvement in US economic data helped lift stocks higher on Thursday, with the FTSE 100 closing at levels not seen in three weeks. London's benchmark index ended the day up 57.7 points at 6,532.44, its highes

5 Sep 13 17:03

Suntory 'in talks' to buy GSK's Ribena, Lucozade

Japanese drinks firm Suntory may make an early pounce for GlaxoSmithKline's Lucozade and Ribena brands in a move that would remove the need for an auction and likely disappoint some quarters of the private equity industry. Suntory, which already owns Orangina Schweppes after buying it four years ag

5 Sep 13 15:34

FTSE 100 movers: M&S leaps after HSBC upgrade

High Street department store Marks & Spencer surged today after HSBC upgraded the stock from 'neutral' to 'overweight', saying it is the most operationally geared among its peers to play on the UK consumer recovery. Hotels group IHG was also a high riser after UBS raised its rating from 'neutral to

5 Sep 13 15:20

UPDATE 3-GSK cancer vaccine disappoints in melanoma trial

* MAGE-A3 vaccine fails to extend disease-free survival in trial * Failure is setback for high-risk, high-reward project * GSK studying if product will help subset of patients * MAGE-A3 treatment also being tested in lung cancer * Shares in GSK partner Agenus fall 33 perce

5 Sep 13 14:36

South Africa's Aspen says talks with GSK over thrombosis drugs continues

JOHANNESBURG, Sept 5 (Reuters) - South Africa's biggest generic drug maker Aspen Pharmacare said on Thursday talks with Britain's GlaxoSmithKline about its $700 bid for drugs and a factory continues. Aspen offered to buy GSK's thrombosis drug brands Arixtra and Fraxiparine, sales of which a

5 Sep 13 14:13

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.